Below you'll find case studies, webinars, blogs, and press releases where we share valuable insights about decentralized clinical trials.
The conversation at SCOPE 2026 wasn't about what's possible in clinical trials — it was about why it's still so hard to execute. Here's what we heard on the ground.
Collaboration adds critical decentralized trial capabilities to the Oracle Life Sciences Clinical One Data Collection solution
Discover how simplifying vaccine logistics can make scientific breakthroughs truly global — and why digital innovation is the missing link in equitable access.
Breaking down barriers in vaccine research: ObvioHealth and Vaxxas team up to advance needle-free vaccine innovation.
SPRIM PRO and ObvioHealth align science and technology to power decentralized and hybrid trial innovation.
As the FDA and HHS initiate a strategic review of the infant formula industry through Operation StorkSpeed, ObvioHealth’s experience in modernizing infant nutrition research offers a timely and relevant model for faster, safer, and more scalable clinical trials.
In response to rising healthcare demands, ObvioHealth is redefining clinical trials through decentralized models and patient-first technology that improves access, engagement, and data quality.